Latest Limited liability partnership Stories
The Firm is actively filing Xarelto lawsuits on behalf of individuals who allegedly suffered life-threatening episodes of Xarelto bleeding and other complications. New
Power morcellators first came to market decades ago, under the FDA’s 510(k) clearance program, which in most cases does not require controlled human testing. New
CHANTILLY, Va., Dec. 17, 2014 /PRNewswire/ -- Redgrave LLP is pleased to announce that Monica McCarroll has joined the firm as Of Counsel and will be based in the Northern Virginia office.
The warning comes as women in the U.S.
The Firm is evaluating power morcellator lawsuits on behalf of women who are also alleged to have experienced the spread of gynecological cancers due to uterine morcellation. New
DUBLIN, December 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/xw5vzm/corporate_counsel) has announced the addition of the "Corporate
In the wake of FDA’s new morcellator cancer warning, a prominent medical group is questioning contraindications recommended by the agency. New York, New York
Parker Waichman LLP successfully asserted its trademark rights and its legitimate interests and rights in this name, prevailing in the arbitration. Port Washington,
NEW YORK, Dec. 4, 2014 /PRNewswire/ -- Wolf Popper LLP is investigating claims on behalf of investors in Avanir Pharmaceuticals, Inc.
HCA is just the latest healthcare provider to reassess the use of power morcellators in light of their potential to spread undetected uterine cancers. New York,
- To give a box on the ear to.